Espinoza Suarez Nataly R, LaVecchia Christina M, Fischer Karen M, Kamath Celia C, Brito Juan P
Knowledge and Evaluation Research (KER) Unit, Mayo Clinic, Rochester, MN.
Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN.
Mayo Clin Proc Innov Qual Outcomes. 2021 Jun 12;5(4):802-810. doi: 10.1016/j.mayocpiqo.2021.05.006. eCollection 2021 Aug.
To understand the impact of cost conversations on the following decision-making outcomes: patients' knowledge about their conditions and treatment options, decisional conflict, and patient involvement.
In 2020 we performed a secondary analysis of a randomly selected set of 220 video recordings of clinical encounters from trials run between 2007 and 2015. Videos were obtained from eight practice-based randomized trials and one pre-post-prospective study comparing care with and without shared decision-making (SDM) tools.
The majority of trial participants were female (61%) and White (86%), with a mean age of 56, some college education (68%), and an income greater than or equal to $40,000 per year (75%), and who did not participate in an encounter aided by an SDM tool (52%). Cost conversations occurred in 106 encounters (48%). In encounters with SDM tools, having a cost conversation lead to lower uncertainty scores (2.1 vs 2.6, =.02), and higher knowledge (0.7 vs 0.6, =.04) and patient involvement scores (20 vs 15.7, =.009) than in encounters using SDM tools where cost conversations did not occur. In a multivariate model, we found slightly worse decisional conflict scores when patients started cost conversations as opposed to when the clinicians started cost conversations. Furthermore, we found higher levels of knowledge when conversations included indirect versus direct cost issues.
Cost conversations have a minimal but favorable impact on decision-making outcomes in clinical encounters, particularly when they occurred in encounters aided by an SDM tool that raises cost as an issue.
了解成本对话对以下决策结果的影响:患者对自身病情和治疗选择的了解、决策冲突以及患者参与度。
2020年,我们对2007年至2015年期间进行的试验中随机选取的22组共220份临床诊疗视频记录进行了二次分析。这些视频来自八项基于实践的随机试验和一项前后瞻性研究,该研究比较了使用和不使用共享决策(SDM)工具的护理情况。
大多数试验参与者为女性(61%),白人(86%),平均年龄56岁,接受过一些大学教育(68%),年收入大于或等于40,000美元(75%),且未参与由SDM工具辅助的诊疗(52%)。成本对话发生在106次诊疗中(48%)。在使用SDM工具的诊疗中,进行成本对话比未进行成本对话的诊疗产生的不确定性得分更低(2.1对2.6,P = 0.02),知识得分更高(0.7对0.6,P = 0.04),患者参与度得分更高(20对15.7,P = 0.009)。在多变量模型中,我们发现患者发起成本对话时的决策冲突得分略高于临床医生发起成本对话时的得分。此外,当对话涉及间接成本问题而非直接成本问题时,患者的知识水平更高。
成本对话对临床诊疗中的决策结果影响极小,但具有积极作用,特别是当它们发生在将成本作为问题提出的SDM工具辅助的诊疗中时。